BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18261355)

  • 21. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
    Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
    Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
    Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
    Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.
    Jurado M; Páramo JA; Gutierrez-Pimentel M; Rocha E
    Thromb Haemost; 1992 Nov; 68(5):516-20. PubMed ID: 1455397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
    Ishizaki T; Itoh R; Yasuda J; Yamamoto T; Okada H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):837-42. PubMed ID: 1534983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK; Chamberlain MA; Menon DK; Davies JA
    Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
    Matsuno K; Araki K
    Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
    Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method].
    von Bilderling P; Spannagl M; Mietaschk A; Iven M; Schramm W; Hess H
    Vasa Suppl; 1991; 33():132-3. PubMed ID: 1788645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemostasis parameters in 55 patients with venous and/or arterial thromboembolisms].
    Thommen D; Buhrfeind E; Felix R; Sulzer I; Furlan M; Lämmle B
    Schweiz Med Wochenschr; 1989 Apr; 119(16):493-9. PubMed ID: 2524096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Massive pulmonary thromboembolism: medical or surgical treatment?].
    Colombi P; Merli M; Zogno M; Pellegrini A
    G Ital Cardiol; 1979; 9(9):984-6. PubMed ID: 520747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
    Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
    Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes induced by venous occlusion in coagulation and fibrinolysis in patients with old myocardial infarction].
    Suzuki T; Yamauchi K; Yamada Y; Furumichi T; Furui H; Saito H
    Kokyu To Junkan; 1991 Jan; 39(1):45-50. PubMed ID: 2024072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy.
    Ballegeer V; Mombaerts P; Declerck PJ; Spitz B; Van Assche FA; Collen D
    Thromb Haemost; 1987 Dec; 58(4):1030-2. PubMed ID: 3445223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis.
    Gries E; Kopp J; Thomae U; Kuhlmann H
    Thromb Haemost; 1990 Jun; 63(3):356-60. PubMed ID: 2205948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
    Mellbring G; Dahlgren S; Wiman B
    Acta Chir Scand; 1985; 151(2):109-14. PubMed ID: 3873768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
    Klein P; Roth FJ; Rieger H; Popov-Cenic S
    Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in parameters of the coagulation-fibrinolysis system and platelet function after OKY-046 administration to patients with ruptured aneurysm of the cerebral artery.
    Kosugi T; Nakamura M; Saitoh S; Noguchi S; Shimoji T; Minei S
    Int J Tissue React; 1991; 13(1):51-7. PubMed ID: 1909691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of fibrinolytic and thrombolytic potential in the rat by treatment with an anabolic steroid, furazabol.
    Kumada T; Abiko Y
    Thromb Haemost; 1976 Nov; 36(2):451-64. PubMed ID: 1036845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of exploratory laparotomy on plasma and peritoneal coagulation/fibrinolysis in horses.
    Baxter GM; Parks AH; Prasse KW
    Am J Vet Res; 1991 Jul; 52(7):1121-7. PubMed ID: 1892267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.